7-108564670-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001130475.3(THAP5):āc.709T>Cā(p.Phe237Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000217 in 1,613,858 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001130475.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
THAP5 | NM_001130475.3 | c.709T>C | p.Phe237Leu | missense_variant | 3/3 | ENST00000415914.4 | NP_001123947.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
THAP5 | ENST00000415914.4 | c.709T>C | p.Phe237Leu | missense_variant | 3/3 | 1 | NM_001130475.3 | ENSP00000400500.2 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152236Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000359 AC: 9AN: 250868Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135748
GnomAD4 exome AF: 0.000230 AC: 336AN: 1461622Hom.: 0 Cov.: 31 AF XY: 0.000217 AC XY: 158AN XY: 727124
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152236Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74378
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2022 | The c.709T>C (p.F237L) alteration is located in exon 3 (coding exon 3) of the THAP5 gene. This alteration results from a T to C substitution at nucleotide position 709, causing the phenylalanine (F) at amino acid position 237 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at